A 6-year-old girl in Texas was given medical marijuana on Thursday to treat her epilepsy — making her the very first person in the state to legally obtain a cannabis product, according to reports.

The child, whose name is being withheld to protect her privacy, received a shipment of low-THC, high-CBD oil from a dispensary called Knox Medical, which is located in the small town of Shulenberg.

The extract was delivered by a nurse, who then showed the youngster how to use it.

“Patients deserve medical relief and Knox Medical is proud to work with physicians and caregivers, and in close coordination with the Texas Department of Public Safety, to provide this medicine that exceeds the most rigorous standards for quality and consistency,” explained José Hidalgo, founder and CEO of Knox Medical.

“This is a historic day for Texas and we will work tirelessly to uphold the trust and responsibility the state has placed in [our company],” he said in a press release. “For Texans suffering from intractable epilepsy, the wait for medical cannabis is finally over.”

Knox, which is based out of Florida, is one of three companies legally allowed to dispense cannabidol in the Lone Star state, according to the Texas Tribune.

The others include Compassionate Cultivation and Surterra Texas, both located in the Austin area.

A spokesperson for Knox told the Tribune that social workers and nurses are the only ones allowed to deliver marijuana products to patients.

While local lawmakers legalized the use of medical marijuana in June 2015 — under the Texas Compassionate Use Act — the industry is just now getting up and running due to all the red tape that was brought with it.

Instead of being able to hawk buds and concentrates, dispensaries are required to sell extracts and oils — with no more than 0.5 percent tetrahydrocannabinol, or THC. Most strains of marijuana, when in plant form, contain 9 percent to 30 percent THC.

Still, the sale of cannabis products — any cannabis products — is a much-welcomed step forward for Texans, especially those who suffer from epilepsy and aren’t able to treat the disorder with traditional medicines.

“In spite of the program’s unreasonably restrictive nature, we’re really happy to see the (cannibidiol) is getting into the hands of at least one patient who needs it,” said Heather Fazio, political director for the Marijuana Policy Project.